{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:40:35Z","timestamp":1782938435834,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.atherosclerosis.2015.11.022","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T07:19:29Z","timestamp":1448435969000},"page":"188-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Soluble CXCL16 and risk of myocardial infarction: The HUNT study in Norway"],"prefix":"10.1016","volume":"244","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1756-9573","authenticated-orcid":false,"given":"Lars E.","family":"Laugsand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn O.","family":"\u00c5svold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars J.","family":"Vatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Janszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Platou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika E.","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fizza","family":"Arain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan K.","family":"Dam\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Epstein","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib3","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib5","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib6","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib7","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.288.8.980","article-title":"Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the women's health initiative observational study","volume":"288","author":"Pradhan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1373\/clinchem.2007.100271","article-title":"Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA\/KORA augsburg cohort study, 1984\u20131998","volume":"54","author":"Koenig","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib12","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0735-1097(02)02953-4","article-title":"C-reactive protein and other inflammatory risk markers in acute coronary syndromes","volume":"41","author":"Blake","year":"2003","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib13","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.jacc.2008.03.019","article-title":"Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease: the RISCA (Recurrence and inflammation in the acute coronary syndromes) study","volume":"51","author":"Bogaty","year":"2008","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib14","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.jacc.2011.08.055","article-title":"High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study","volume":"58","author":"Cristell","year":"2011","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib15","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/ATVBAHA.107.161240","article-title":"Chemokines and cardiovascular risk, arteriosclerosis","volume":"28","author":"Aukrust","year":"2008","journal-title":"Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.107.695189","article-title":"Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood a critical role for p-selectin expressed on activated platelets","volume":"116","author":"Schulz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/19546","article-title":"MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions","volume":"398","author":"Gerszten","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cvr\/cvn071","article-title":"High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins","volume":"79","author":"Smith","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib19","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.ATV.0000124102.11472.36","article-title":"CXCL16\/SR-PSOX is an interferon-\u03b3\u2013regulated chemokine and scavenger receptor expressed in atherosclerotic lesions, arteriosclerosis","volume":"24","author":"Wuttge","year":"2004","journal-title":"Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib20","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/hq1001.096652","article-title":"Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions","volume":"21","author":"Minami","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.105.540583","article-title":"Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis","volume":"114","author":"Aslanian","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib22","doi-asserted-by":"crossref","first-page":"40663","DOI":"10.1074\/jbc.C000761200","article-title":"Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages","volume":"275","author":"Shimaoka","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib23","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1161\/CIRCULATIONAHA.108.806877","article-title":"Soluble CXCL16 predicts long-term mortality in acute coronary syndromes","volume":"119","author":"Jansson","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1160\/TH07-01-0029","article-title":"Chemokines in cardiovascular risk prediction","volume":"97","author":"Aukrust","year":"2007","journal-title":"Thromb. Haemost. Stuttg."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib25","first-page":"19","article-title":"The Nord-Tr\u00f8ndelag health study 1995\u201397 (HUNT 2): objectives, contents, methods and participation","volume":"13","author":"Holmen","year":"2003","journal-title":"Nor. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib26","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/CIRCULATIONAHA.111.025858","article-title":"Insomnia and the risk of acute myocardial infarction","volume":"124","author":"Laugsand","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","volume":"36","author":"Antman","year":"2000","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib28","series-title":"Modern Epidemiology","author":"Rothman","year":"2008"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01621459.1983.10477915","article-title":"Multiplicative models and cohort analysis","volume":"78","author":"Breslow","year":"1983","journal-title":"J.\u00a0Am. Stat. Assoc."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib30","series-title":"Modern Epidemiology","author":"Rothman","year":"2008"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jacc.2006.09.034","article-title":"CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans","volume":"49","author":"Lehrke","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1620\/tjem.223.277","article-title":"CXC chemokine ligand 16 as a prognostic marker in patients with intermediate coronary artery lesions: a 2-year follow-up study","volume":"223","author":"Tan","year":"2011","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.atherosclerosis.2011.10.004","article-title":"Soluble CXCL16 and long-term outcome in acute ischemic stroke","volume":"220","author":"Ueland","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/jama.2011.163","article-title":"Index event bias as an explanation for the paradoxes of recurrence risk research","volume":"305","author":"Dahabreh","year":"2011","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2009.11.004","article-title":"An intron polymorphism in the CXCL16 gene is associated with increased risk of coronary artery disease in Chinese Han population: a large angiography-based study","volume":"210","author":"Huang","year":"2010","journal-title":"Atherosclerosis"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2015.11.022_bib36","first-page":"1447","article-title":"Chemokine CXC Ligand 16 serum concentration but not A181V genotype is associated with atherosclerotic stroke","volume":"411","author":"Liu","year":"2010","journal-title":"Clin. Chim. Actas"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.STR.0000048845.83285.AC","article-title":"Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers","volume":"34","author":"Magyar","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2015.11.022_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9149(03)00537-X","article-title":"Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index","volume":"92","author":"McDermott","year":"2003","journal-title":"Am. J. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015302185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015302185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T18:31:21Z","timestamp":1567362681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015302185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":38,"alternative-id":["S0021915015302185"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.11.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble CXCL16 and risk of myocardial infarction: The HUNT study in Norway","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}